EPIDERMOLYSIS BULLOSA DYSTROPHICA
Clinical trials for EPIDERMOLYSIS BULLOSA DYSTROPHICA explained in plain language.
Never miss a new study
Get alerted when new EPIDERMOLYSIS BULLOSA DYSTROPHICA trials appear
Sign up with your email to follow new studies for EPIDERMOLYSIS BULLOSA DYSTROPHICA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Custom skin patch offers hope for rare blistering condition
Disease control OngoingThis study tests a lab-made skin substitute on one patient with dystrophic epidermolysis bullosa, a rare disease causing fragile skin and chronic wounds. The goal is to cover open sores that haven't healed with standard treatments. Researchers will measure wound shrinkage, healin…
Matched conditions: EPIDERMOLYSIS BULLOSA DYSTROPHICA
Phase: EARLY_PHASE1 • Sponsor: CHU de Quebec-Universite Laval • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
AI app could catch deadly skin cancer early in rare disease patients
Diagnosis OngoingThis study is creating an artificial intelligence (AI) app that can detect a dangerous type of skin cancer called squamous cell carcinoma (SCC) from photos taken by patients or their families. The app is designed for people with recessive dystrophic epidermolysis bullosa (RDEB), …
Matched conditions: EPIDERMOLYSIS BULLOSA DYSTROPHICA
Sponsor: Northwestern University • Aim: Diagnosis
Last updated May 19, 2026 12:01 UTC
-
Turmeric and light: a new hope for painful blisters?
Symptom relief OngoingThis study tests whether a light-activated curcumin gel can heal painful mouth sores in people with epidermolysis bullosa, a rare skin-blistering condition. Twenty participants will receive the treatment for three days, and researchers will track healing and quality of life. The …
Matched conditions: EPIDERMOLYSIS BULLOSA DYSTROPHICA
Phase: PHASE4 • Sponsor: Universidade Ceuma • Aim: Symptom relief
Last updated May 20, 2026 12:07 UTC